Alger Jason 4
4 · Health Catalyst, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst (HCAT) CFO Jason Alger Sells 18,804 Shares
What Happened
Jason Alger, Chief Financial Officer of Health Catalyst, sold 18,804 shares on 2026-06-01 at $1.37 per share, for proceeds of $25,765. The sale was a "sell-to-cover" tied to the vesting of restricted stock units (RSUs) to satisfy tax withholding obligations rather than a discretionary open-market sale.
Key Details
- Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely within the 2-business-day filing window).
- Shares disposed: 18,804 at $1.37 each; total proceeds $25,765.
- Shares owned after transaction: Not specified in the filing.
- Footnote: F1 — shares were sold to cover tax withholding on vested RSUs as required by the issuer's equity plan; this was not a discretionary trade.
- Transaction code: F (payment of exercise price or tax liability / tax withholding).
Context
This was a routine sell-to-cover following RSU vesting, commonly used by companies to satisfy payroll tax withholding and does not necessarily indicate the insider's view of the company's prospects. The filing shows no option exercise or separate open-market sale—just the mandated withholding sale of vested shares.
Insider Transaction Report
Form 4
Alger Jason
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-06-01$1.37/sh−18,804$25,765→ 722,840 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Signature
/s/Benjamin Landry, as Attorney-in-Fact|2026-06-03